|
Market Closed -
OTC Markets
12:26:41 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +163.64% |
|
0.00% | -90.52% |
| 04-15 | CS Diagnostics Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-14 | CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: CS Diagnostics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Market Cap 1 | 0.3951 | 150.6 | 76.47 |
| Change | - | 38,005.96% | -49.21% |
| Enterprise Value (EV) 1 | 0.3747 | 150.6 | 76.47 |
| Change | - | 40,076.48% | -49.21% |
| P/E | -2,525x | 232,000x | 1,077x |
| PBR | 0.11x | 0.32x | 0.15x |
| PEG | - | -2,263x | 0x |
| Capitalization / Revenue | 3.13x | 1,357x | 375x |
| EV / Revenue | 2.97x | 1,357x | 375x |
| EV / EBITDA | - | - | - |
| EV / EBIT | -17x | 197,840x | 1,074x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.000198 | 0.000005 | 0.000284 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.126 | 0.1109 | 0.204 |
| EBITDA | - | - | - |
| EBIT 1 | -0.022 | 0.000761 | 0.0712 |
| Net income 1 | -0.022 | 0.000761 | 0.0712 |
| Net Debt 1 | -0.0204 | -0.000501 | -0.006813 |
| Reference price 2 | 0.5000 | 1.1600 | 0.3059 |
| Nbr of stocks (in thousands) | 790 | 129,790 | 249,992 |
| Announcement Date | 7/29/25 | 7/29/25 | 4/15/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 7.25M | ||
| 30.19x | 4.1x | 15.74x | 2.44% | 182B | ||
| 19.44x | 3.55x | 12.69x | 3.09% | 118B | ||
| 17.7x | 0.21x | 12.92x | 0.74% | 61.7B | ||
| 28.46x | 7x | 18.03x | 1.4% | 50.55B | ||
| 34.65x | 3.36x | 11.52x | 2.18% | 48.98B | ||
| 33.62x | 5.91x | 18.54x | -.--% | 31.65B | ||
| 43.96x | 1.28x | 11.86x | 0.21% | 29.87B | ||
| 39.29x | 6.88x | 24.67x | 0.27% | 23.71B | ||
| 16.9x | 2.69x | 9.55x | 1.64% | 21.78B | ||
| Average | 29.36x | 3.89x | 15.06x | 1.33% | 56.79B | |
| Weighted average by Cap. | 27.62x | 3.77x | 14.73x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSDX Stock
- Valuation CS Diagnostics Corp.
Select your edition
All financial news and data tailored to specific country editions
















